Friday, June 26, 2020

Artiva Biotherapeutics Raises $78M For Cancer Therapy

San Diego-based Artiva Biotherapeutics has raised $78M in a Series A funding round, for its cancer therapies, the company said late Thursday. According to the company, the financing was co-led by 5AM Ventures, venBio Partners, and RA Capital Management, and also included Medivate Partners and seed investors and strategic partners GC LabCell (Green Cros

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.